For more than 30 years, the highly regarded Secrets Series® has provided students and practitioners in all areas of health care with concise, focused, and engaging resources for quick reference and exam review. Nephrology Secrets, 4th Edition, features the Secrets’ popular question-and-answer format that also includes lists, tables, and an easy-to-read style – making reference and review quick, easy, and enjoyable.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedication - p. v 6. Contributors - p. vi 7. Preface - p. vii 8. Top 100 secrets - p. viii 9. I. Patient Assessment - p. ix 10. 1. History and physical diagnosis - p. ix 11. 2. Urinalysis - p. 6 12. 3. Measurement of glomerular filtration rate - p. 13 13. 4. Kidney imaging techniques - p. 22 14. 5. Kidney biopsy - p. 29 15. II. Acute Kidney Injury - p. 33 16. 6. Epidemiology, etiology, pathophysiology, and diagnosis - p. 33 17. 7. Management options: Continuous renal replacement therapy - p. 43 18. 8. Hepatorenal syndrome - p. 49 19. 9. Cardiorenal syndrome - p. 56 20. 10. Medications - p. 66 21. 11. Sepsis - p. 71 22. 12. Rhabdomyolysis - p. 77 23. 13. Contrast-induced nephropathy - p. 81 24. 14. Acute glomerulonephritis and rapidly progressive glomerulonephritis - p. 87 25. 15. Nephrotic syndrome - p. 93 26. 16. Obstructive uropathy - p. 98 27. 17. Nephrolithiasis - p. 101 28. III. Chronic Kidney Disease - p. 107 29. 18. Epidemiology, etiology, pathophysiology, and staging of chronic kidney disease - p. 107 30. 19. Anemia in chronic kidney disease - p. 114 31. 20. Bone and mineral metabolism - p. 120 32. 21. Cardiovascular disease - p. 129 33. 22. Dyslipidemia - p. 134 34. 23. Nutrition - p. 140 35. 24. Clinical management of chronic kidney disease - p. 146 36. 25. Drug dosing in patients with chronic kidney disease - p. 154 37. IV. Primary Glomerular Disorders - p. 161 38. 26. Minimal change disease - p. 161 39. 27. Focal segmental glomerulosclerosis - p. 166 40. 28. Membranous nephropathy - p. 173 41. 29. Immunoglobulin a nephropathy and Henoch–Schönlein disease - p. 178 42. 30. Membranoproliferative glomerulonephritis - p. 184 43. V. Secondary Glomerular Disorders - p. 190 44. 31. Diabetic kidney disease - p. 190 45. 32. Lupus nephritis - p. 195 46. 33. Vasculitides - p. 202 47. VI. Infection-Associated Glomerulonephritides - p. 207 48. 34. Streptococcal- and staphylococcal-related glomerulonephritis - p. 207 49. 35. Viral hepatitis-associated glomerulonephritis - p. 212 50. 36. Human immunodeficiency virus–associated kidney disorders - p. 220 51. VII. Onconephrology - p. 226 52. 37. Onconephrology - p. 226 53. 38. Tumor lysis syndrome - p. 234 54. 39. Dysproteinemias or light chain diseases - p. 238 55. 40. Kidney neoplasias - p. 248 56. 41. Thrombotic microangiopathies - p. 252 57. VIII. Other Renal Parenchymal Diseases - p. 257 58. 42. Fabry disease - p. 257 59. 43. Cystic diseases of the kidneys - p. 260 60. 44. Other hereditary kidney disorders - p. 271 61. 45. Tubulointerstitial diseases - p. 275 62. 46. Urinary tract infection - p. 284 63. IX. Kidney Diseases in Special Populations - p. 292 64. 47. Kidney disease and hypertension in pregnancy - p. 292 65. 48. Sickle cell nephropathy - p. 297 66. 49. Kidney diseases in the elderly - p. 303 67. 50. Kidney diseases in african americans - p. 309 68. X. Treatment Options - p. 314 69. 51. Hemodialysis - p. 314 70. 52. Home dialysis - p. 322 71. 53. Peritoneal dialysis - p. 326 72. 54. Therapeutic plasma exchange (plasmapheresis) - p. 344 73. XI. Transplantation - p. 348 74. 55. Epidemiology and outcomes - p. 348 75. 56. Donor and recipient evaluation - p. 354 76. 57. Immunosuppression - p. 359 77. 58. Rejection of the kidney transplant - p. 364 78. 59. Posttransplant malignancies - p. 368 79. 60. Posttransplant infections - p. 372 80. 61. Primary care of the kidney transplant recipient - p. 376 81. XII. Hypertension - p. 381 82. 62. Primary hypertension - p. 381 83. 63. Kidney parenchymal hypertension - p. 386 84. 64. Renovascular disease - p. 392 85. 65. Endocrine hypertension - p. 397 86. 66. Other forms of secondary hypertension - p. 408 87. 67. Resistant hypertension - p. 413 88. 68. Hypertensive emergencies - p. 419 89. 69. Pharmacologic treatment of hypertension - p. 425 90. 70. Nonpharmacologic treatment of hypertension - p. 429 91. XIII. Acid-Base and Electrolyte Disorders - p. 433 92. 71. Volume disorders and assessment - p. 433 93. 72. Genetic disorders of sodium transport - p. 444 94. 73. Dysnatremias - p. 451 95. 74. Hypokalemia and hyperkalemia - p. 459 96. 75. Hypocalcemia and hypercalcemia - p. 465 97. 76. Disorders of phosphorus metabolism - p. 471 98. 77. Disorders of magnesium metabolism - p. 477 99. 78. Metabolic acidosis - p. 486 100. 79. Metabolic alkalosis - p. 505 101. XIV. Palliative Care in Nephrology - p. 513 102. 80. Palliative care in nephrology - p. 513 103. XV. Nephrology Beginnings - p. 520 104. 81. Nephrology beginnings - p. 520 105. Index - p. 529
For more than 30 years, the highly regarded Secrets Series® has provided students and practitioners in all areas of health care with concise, focused, and engaging resources for quick reference and exam review. Nephrology Secrets, 4th Edition, features the Secrets’ popular question-and-answer format that also includes lists, tables, and an easy-to-read style – making reference and review quick, easy, and enjoyable.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedication - p. v 6. Contributors - p. vi 7. Preface - p. vii 8. Top 100 secrets - p. viii 9. I. Patient Assessment - p. ix 10. 1. History and physical diagnosis - p. ix 11. 2. Urinalysis - p. 6 12. 3. Measurement of glomerular filtration rate - p. 13 13. 4. Kidney imaging techniques - p. 22 14. 5. Kidney biopsy - p. 29 15. II. Acute Kidney Injury - p. 33 16. 6. Epidemiology, etiology, pathophysiology, and diagnosis - p. 33 17. 7. Management options: Continuous renal replacement therapy - p. 43 18. 8. Hepatorenal syndrome - p. 49 19. 9. Cardiorenal syndrome - p. 56 20. 10. Medications - p. 66 21. 11. Sepsis - p. 71 22. 12. Rhabdomyolysis - p. 77 23. 13. Contrast-induced nephropathy - p. 81 24. 14. Acute glomerulonephritis and rapidly progressive glomerulonephritis - p. 87 25. 15. Nephrotic syndrome - p. 93 26. 16. Obstructive uropathy - p. 98 27. 17. Nephrolithiasis - p. 101 28. III. Chronic Kidney Disease - p. 107 29. 18. Epidemiology, etiology, pathophysiology, and staging of chronic kidney disease - p. 107 30. 19. Anemia in chronic kidney disease - p. 114 31. 20. Bone and mineral metabolism - p. 120 32. 21. Cardiovascular disease - p. 129 33. 22. Dyslipidemia - p. 134 34. 23. Nutrition - p. 140 35. 24. Clinical management of chronic kidney disease - p. 146 36. 25. Drug dosing in patients with chronic kidney disease - p. 154 37. IV. Primary Glomerular Disorders - p. 161 38. 26. Minimal change disease - p. 161 39. 27. Focal segmental glomerulosclerosis - p. 166 40. 28. Membranous nephropathy - p. 173 41. 29. Immunoglobulin a nephropathy and Henoch–Schönlein disease - p. 178 42. 30. Membranoproliferative glomerulonephritis - p. 184 43. V. Secondary Glomerular Disorders - p. 190 44. 31. Diabetic kidney disease - p. 190 45. 32. Lupus nephritis - p. 195 46. 33. Vasculitides - p. 202 47. VI. Infection-Associated Glomerulonephritides - p. 207 48. 34. Streptococcal- and staphylococcal-related glomerulonephritis - p. 207 49. 35. Viral hepatitis-associated glomerulonephritis - p. 212 50. 36. Human immunodeficiency virus–associated kidney disorders - p. 220 51. VII. Onconephrology - p. 226 52. 37. Onconephrology - p. 226 53. 38. Tumor lysis syndrome - p. 234 54. 39. Dysproteinemias or light chain diseases - p. 238 55. 40. Kidney neoplasias - p. 248 56. 41. Thrombotic microangiopathies - p. 252 57. VIII. Other Renal Parenchymal Diseases - p. 257 58. 42. Fabry disease - p. 257 59. 43. Cystic diseases of the kidneys - p. 260 60. 44. Other hereditary kidney disorders - p. 271 61. 45. Tubulointerstitial diseases - p. 275 62. 46. Urinary tract infection - p. 284 63. IX. Kidney Diseases in Special Populations - p. 292 64. 47. Kidney disease and hypertension in pregnancy - p. 292 65. 48. Sickle cell nephropathy - p. 297 66. 49. Kidney diseases in the elderly - p. 303 67. 50. Kidney diseases in african americans - p. 309 68. X. Treatment Options - p. 314 69. 51. Hemodialysis - p. 314 70. 52. Home dialysis - p. 322 71. 53. Peritoneal dialysis - p. 326 72. 54. Therapeutic plasma exchange (plasmapheresis) - p. 344 73. XI. Transplantation - p. 348 74. 55. Epidemiology and outcomes - p. 348 75. 56. Donor and recipient evaluation - p. 354 76. 57. Immunosuppression - p. 359 77. 58. Rejection of the kidney transplant - p. 364 78. 59. Posttransplant malignancies - p. 368 79. 60. Posttransplant infections - p. 372 80. 61. Primary care of the kidney transplant recipient - p. 376 81. XII. Hypertension - p. 381 82. 62. Primary hypertension - p. 381 83. 63. Kidney parenchymal hypertension - p. 386 84. 64. Renovascular disease - p. 392 85. 65. Endocrine hypertension - p. 397 86. 66. Other forms of secondary hypertension - p. 408 87. 67. Resistant hypertension - p. 413 88. 68. Hypertensive emergencies - p. 419 89. 69. Pharmacologic treatment of hypertension - p. 425 90. 70. Nonpharmacologic treatment of hypertension - p. 429 91. XIII. Acid-Base and Electrolyte Disorders - p. 433 92. 71. Volume disorders and assessment - p. 433 93. 72. Genetic disorders of sodium transport - p. 444 94. 73. Dysnatremias - p. 451 95. 74. Hypokalemia and hyperkalemia - p. 459 96. 75. Hypocalcemia and hypercalcemia - p. 465 97. 76. Disorders of phosphorus metabolism - p. 471 98. 77. Disorders of magnesium metabolism - p. 477 99. 78. Metabolic acidosis - p. 486 100. 79. Metabolic alkalosis - p. 505 101. XIV. Palliative Care in Nephrology - p. 513 102. 80. Palliative care in nephrology - p. 513 103. XV. Nephrology Beginnings - p. 520 104. 81. Nephrology beginnings - p. 520 105. Index - p. 529
